Goldman Sachs Group Inc Frazier Lifesciences Acquisition Corp Transaction History

Goldman Sachs Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 14, 2024	SELL	$0.62 - $9.97 $2,354 - $37,866	-3,798 Reduced 0.76%	497,489 $4.96 Million
Q3 2022 Nov 10, 2022	SELL	$0.62 - $9.97 $2,354 - $37,866	-3,798 Reduced 0.76%	497,489 $0
Q2 2022 May 14, 2024	BUY	$9.83 - $9.9 $4.93 Million - $4.96 Million	501,287 New	501,287 $4.95 Million
Q2 2022 Aug 15, 2022	SELL	$9.83 - $9.9 $197,199 - $198,603	-20,061 Reduced 3.85%	501,287 $4.95 Million
Q1 2022 May 16, 2022	BUY	$9.75 - $9.85 $5.08 Million - $5.14 Million	521,348 New	521,348 $5.13 Million

Ticker FLAC
Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Shares Outstandng 14,301,000
Description
Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.